Endometrial Adenocarcinoma Clinical Trials

6 recruiting

Frequently Asked Questions

Common questions about Endometrial Adenocarcinoma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 2

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Recurrent Endometrial CarcinomaEndometrial AdenocarcinomaEndometrial Clear Cell Adenocarcinoma+6 more
National Cancer Institute (NCI)81 enrolled136 locationsNCT05112601
Recruiting
Phase 2

A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia

Endometrioid Endometrial Adenocarcinoma
University of Florida20 enrolled1 locationNCT07107334
Recruiting
Phase 2

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

Endometrial Adenocarcinoma
Acrivon Therapeutics353 enrolled90 locationsNCT05548296
Recruiting
Phase 1Phase 2

A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

Triple-Negative Breast CancerColorectal, CancerOvarian Cancer+6 more
Apollo Therapeutics Ltd100 enrolled9 locationsNCT06399757
Recruiting

Surgical and Obstetric Outcomes in Endometrial Adenocarcinoma and Atypical Endometrial Hyperplasia With Conservative Treatment

Fertility PreservationEndometrial AdenocarcinomaEndometrial Hyperplasia+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS100 enrolled1 locationNCT07077876
Recruiting
Phase 2

QL1706-Based Therapy Post-PD-1/L1 Failure in Advanced Endometrial Cancer

Endometrial CancerEndometrial Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital30 enrolled1 locationNCT06917092
Recruiting
Not Applicable

PErsonalized TReatment for Endometrial Carcinoma

Endometrial Adenocarcinoma
University of Helsinki300 enrolled1 locationNCT05655260
Recruiting
Phase 2

SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)

Mmr DeficiencyImmune-related Adverse EventEndometrial Cancer Stage I+1 more
Queensland Centre for Gynaecological Cancer10 enrolled3 locationsNCT06278857